We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+28.15%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$448M
AUM Growth
+$56.1M
Cap. Flow
+$34.8M
Cap. Flow %
7.76%
Top 10 Hldgs %
58.47%
Holding
175
New
33
Increased
39
Reduced
41
Closed
56

Top Buys

Rank Stock Value
1
CIVI
Civitas Resources
CIVI
+$3.77M
2
CNC icon
Centene
CNC
+$3.66M
3
DIN icon
Dine Brands
DIN
+$3.44M
4
LMT icon
Lockheed Martin
LMT
+$3.21M
5
FE icon
FirstEnergy
FE
+$2.65M

Top Sells

Rank Stock Value
1
HSII
Heidrick & Struggles
HSII
+$4.62M
2
CHL
China Mobile Limited
CHL
+$4.42M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$3.37M
4
MIK
Michaels Stores, Inc
MIK
+$3M
5
SKT icon
Tanger
SKT
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 7.42%
2 Financials 6.92%
3 Consumer Discretionary 6.46%
4 Materials 5.99%
5 Healthcare 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SFE
101
DELISTED
Safeguard Scientifics, Inc.
SFE
$440K 0.1%
+64,563
New +$469K
SLGN icon
102
Silgan Holdings
SLGN
$4.35B
$437K 0.1%
+10,410
New +$406K
RVI
103
DELISTED
Retail Value Inc. Common Shares
RVI
$431K 0.1%
+250,604
New +$385K
USAP
104
DELISTED
Universal Stainless & Alloy
USAP
$427K 0.1%
42,011
-4,370
-9% -$40K
OI icon
105
O-I Glass
OI
$1.08B
$379K 0.08%
25,703
-3,249
-11% -$41.9K
AGFS
106
DELISTED
AgroFresh Solutions Inc
AGFS
$361K 0.08%
+180,661
New +$405K
ORN icon
107
Orion Group Holdings
ORN
$396M
$359K 0.08%
+59,142
New +$340K
SPOK icon
108
Spok Holdings
SPOK
$237M
$359K 0.08%
34,192
-90,130
-72% -$1.03M
SRGA
109
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$337K 0.08%
+5,154
New +$360K
GSV
110
DELISTED
Gold Standard Ventures Corp.
GSV
$297K 0.07%
512,074
-55,384
-10% -$37.5K
VEON icon
111
VEON
VEON
$3.87B
$218K 0.05%
+4,936
New +$216K
WW
112
DELISTED
WW International
WW
$199K 0.04%
6,352
-58,575
-90% -$1.69M
BIOX icon
113
Bioceres Crop Solutions
BIOX
$22.8M
$195K 0.04%
+19,121
New +$160K
BSVN icon
114
Bank7 Corp
BSVN
$482M
$183K 0.04%
+10,403
New +$174K
EQT icon
115
EQT Corp
EQT
$33.8B
$177K 0.04%
9,486
-1,143
-11% -$19.9K
IBM icon
116
IBM
IBM
$223B
$130K 0.03%
1,016
-119
-10% -$14.2K
TEN
117
CALL
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$83K 0.02%
7,700
– –
SRAX
118
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$78K 0.02%
16,483
-1,998
-11% -$8.35K
STR
119
DELISTED
Sitio Royalties
STR
$64K 0.01%
3,532
-105,218
-97% -$1.67M
ALOT icon
120
AstroNova
ALOT
$226M
– –
-32,214
Closed -$343K
AP.WS
121
DELISTED
Ampco-Pittsburgh Corp Series A Warrants
AP.WS
– –
-193,742
Closed -$171K
ATRO icon
122
Astronics
ATRO
$3.72B
– –
-26,089
Closed -$288K
BDC icon
123
Belden
BDC
$5.28B
– –
-58,528
Closed -$2.45M
BHR
124
Braemar Hotels & Resorts
BHR
$139M
– –
-49,588
Closed -$228K
SRTAW
125
CALL
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
– –
-115,962
Closed -$284K
3 4
5
6 7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Invenomic Capital Management held 175 positions worth $448M, up 14% from $392M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Invenomic Capital Management deployed $34.8M of net new capital in Q1 2021, opening 33 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 59,072 shares worth $3.78M.

By sector, the portfolio is most concentrated in Industrials at 7.4% of assets, up from 6.8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Discovery, Inc. Series C Common Stock, an estimated $3.37M trimmed.

  • Invenomic Capital Management's largest Q1 2021 buy was Centene: 59,072 shares worth $3.78M.
  • Invenomic Capital Management added most to Civitas Resources in Q1 2021, an estimated $3.77M increase.
  • Invenomic Capital Management's biggest Q1 2021 reduction was Discovery, Inc. Series C Common Stock, cutting an estimated $3.37M.
  • Invenomic Capital Management fully exited Heidrick & Struggles in Q1 2021, selling an estimated $4.62M.
  • Invenomic Capital Management's ten largest holdings make up 58% of its $448M portfolio in Q1 2021.
  • Invenomic Capital Management opened 33 new positions and closed 56 in Q1 2021.
  • Invenomic Capital Management's portfolio value rose 14% quarter-over-quarter to $448M.

Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.